Yi Sui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yi Sui has a total of 392 co-authors. Here are the top co-authors by number of shared publications:
- Bing Xu
Department of Neurology, Chest Hospital of Shenyang Pharmaceutical University
8 shared publications - Tingyu Yi
Department of Neurointervention, Zhangzhou Affiliated Hospital of Fujian Medical University
5 shared publications - Wenhuo Chen
Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China (W.C.).
5 shared publications - Xia Wang
The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (X.W.).
5 shared publications Yao Zhang
Department of Neurology, Shenyang First People's Hospital Shenyang Medical College Affiliated Brain Hospital Shenyang China
5 shared publications- Craig Stuart Anderson
The George Institute for Global Health, University of New South Wales, Sydney, Australia
4 shared publications
Latest Publications
- 12 June 2026
- Published by S. Karger AG in Cerebrovascular Diseases
- p. 1-23
Achieving the ‘golden hour’: evaluating and optimising the spatial distribution of comprehensive stroke centers in Liaoning Province, China
Background: Efficient spatial layout of comprehensive stroke centers (CSCs) is crucial for the timely transport of stroke patients to hospitals for effective treatment following symptom onset. However, limited research has focused on the spatial allocation of CSCs. Therefore, this study aimed to evaluate the spatial distribution and accessibility of CSCs in Liaoning Province, China. Methods: The closest-facility analysis and location-allocation model were employed to examine spatial accessibility, urban-rural disparities, and 1-hour coverage of the high-risk population under current and simulated CSC distribution scenarios. Results: Key findings include: (1) CSC accessibility in Liaoning Province varies significantly, with better accessibility in major cities and poorer accessibility in mountainous and rural areas. (2) The existing 34 CSCs were mainly located in urban areas, and only 48.41% of townships and 60.63% of the high-risk population in Liaoning province can access them within 1 h. (3) In the optimization scenario, considering only candidate tertiary hospitals extended coverage to 75.63% of the high-risk populations. Integrating both candidate tertiary and secondary hospitals increased coverage in high-risk populations to 89.78%, effectively increasing the accessibility of CSCs, particularly in rural areas, and reducing the urban-rural accessibility gap. Conclusion: These insights shed light on the spatial disparities of CSCs in Liaoning Province and provide a spatial blueprint for establishing a “1-hour gold rescue circle”. While improving geographic accessibility is a prerequisite, future policy should also prioritize the capacity building of candidate hospitals to ensure clinical efficacy.
- 12 June 2026
- Published by S. Karger AG in Cerebrovascular Diseases
- p. 1-23
Achieving the ‘golden hour’: evaluating and optimising the spatial distribution of comprehensive stroke centers in Liaoning Province, China
Background: Efficient spatial layout of comprehensive stroke centers (CSCs) is crucial for the timely transport of stroke patients to hospitals for effective treatment following symptom onset. However, limited research has focused on the spatial allocation of CSCs. Therefore, this study aimed to evaluate the spatial distribution and accessibility of CSCs in Liaoning Province, China. Methods: The closest-facility analysis and location-allocation model were employed to examine spatial accessibility, urban-rural disparities, and 1-hour coverage of the high-risk population under current and simulated CSC distribution scenarios. Results: Key findings include: (1) CSC accessibility in Liaoning Province varies significantly, with better accessibility in major cities and poorer accessibility in mountainous and rural areas. (2) The existing 34 CSCs were mainly located in urban areas, and only 48.41% of townships and 60.63% of the high-risk population in Liaoning province can access them within 1 h. (3) In the optimization scenario, considering only candidate tertiary hospitals extended coverage to 75.63% of the high-risk populations. Integrating both candidate tertiary and secondary hospitals increased coverage in high-risk populations to 89.78%, effectively increasing the accessibility of CSCs, particularly in rural areas, and reducing the urban-rural accessibility gap. Conclusion: These insights shed light on the spatial disparities of CSCs in Liaoning Province and provide a spatial blueprint for establishing a “1-hour gold rescue circle”. While improving geographic accessibility is a prerequisite, future policy should also prioritize the capacity building of candidate hospitals to ensure clinical efficacy.
- 1 March 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (3) , 587-596
Low-Intensity Monitoring for Mild-to-Moderate Acute Ischemic Stroke Is Cost Saving: Economic Evaluation for OPTIMISTmain
BACKGROUND: OPTIMISTmain (Main Optimal Post rtPA-IV Monitoring in Ischemic Stroke Trial) has shown that low-intensity monitoring is feasible and safe compared with standard monitoring in stable patients who receive thrombolysis treatment for acute ischemic stroke of mild-to-moderate neurological impairment. We aimed to estimate the economic benefits of low-intensity care compared with standard care. METHODS: A cost-minimization analysis based on OPTIMISTmain was conducted for Australia, China, Malaysia, the United Kingdom, the United States, and Vietnam. A decision tree model comprising 2 arms was developed from the trial design. State transition probabilities for each country were extracted from the trial, and cost data were sourced from the existing literature. Mean costs over the 90-day duration of follow-up were compared, and univariate and probabilistic sensitivity and scenario analyses were performed. RESULTS: Low-intensity monitoring had the highest probability of cost saving in China (100.00%) and the United Kingdom (100.00%), followed by Australia (99.94%), the United States (95.91%), and Vietnam (86.66%), as patients in this group incurred US dollars savings of 239, 133, 647, 943, and 3 in direct costs compared with patients in the standard group, respectively. In Malaysia, however, the intervention costs slightly exceeded those for standard care (US dollars 5643 versus 5378). Countries with higher proportions of patients having intensive care unit monitoring had greater cost savings. Cost-saving thresholds of monitoring costs were 1.24, 1.30, 1.26, 1.24, 1.01, and 0.91 times the base case value in Australia, China, the United Kingdom, the United States, Vietnam, and Malaysia, respectively. CONCLUSIONS: The low-intensity monitoring protocol was cost saving in countries with high proportions of intensive care resources for postthrombolysis treatment monitoring, such as in the United States. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03734640. URL: https://www.anzctr.org.au/ ; Unique identifier: ACTRN 12619001556134p.
- 1 March 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (3) , 587-596
Low-Intensity Monitoring for Mild-to-Moderate Acute Ischemic Stroke Is Cost Saving: Economic Evaluation for OPTIMISTmain
BACKGROUND: OPTIMISTmain (Main Optimal Post rtPA-IV Monitoring in Ischemic Stroke Trial) has shown that low-intensity monitoring is feasible and safe compared with standard monitoring in stable patients who receive thrombolysis treatment for acute ischemic stroke of mild-to-moderate neurological impairment. We aimed to estimate the economic benefits of low-intensity care compared with standard care. METHODS: A cost-minimization analysis based on OPTIMISTmain was conducted for Australia, China, Malaysia, the United Kingdom, the United States, and Vietnam. A decision tree model comprising 2 arms was developed from the trial design. State transition probabilities for each country were extracted from the trial, and cost data were sourced from the existing literature. Mean costs over the 90-day duration of follow-up were compared, and univariate and probabilistic sensitivity and scenario analyses were performed. RESULTS: Low-intensity monitoring had the highest probability of cost saving in China (100.00%) and the United Kingdom (100.00%), followed by Australia (99.94%), the United States (95.91%), and Vietnam (86.66%), as patients in this group incurred US dollars savings of 239, 133, 647, 943, and 3 in direct costs compared with patients in the standard group, respectively. In Malaysia, however, the intervention costs slightly exceeded those for standard care (US dollars 5643 versus 5378). Countries with higher proportions of patients having intensive care unit monitoring had greater cost savings. Cost-saving thresholds of monitoring costs were 1.24, 1.30, 1.26, 1.24, 1.01, and 0.91 times the base case value in Australia, China, the United Kingdom, the United States, Vietnam, and Malaysia, respectively. CONCLUSIONS: The low-intensity monitoring protocol was cost saving in countries with high proportions of intensive care resources for postthrombolysis treatment monitoring, such as in the United States. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03734640. URL: https://www.anzctr.org.au/ ; Unique identifier: ACTRN 12619001556134p.
- Open Access
- 7 August 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (8) , e70566
Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes
- 7 August 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (8) , e70566
Open AccessReconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes
- Open Access
- 31 July 2025
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 19, 1617682
Role and regulatory mechanism of GPR37 in neurological diseases
G protein-coupled receptor 37 is an orphan Class A GPCR predominantly expressed in the central nervous system (CNS), implicated in diverse physiological and pathological processes. This review summarizes current advances in the structural and functional understanding of GPR37, including its genomic localization, receptor architecture, endogenous ligands, and downstream signaling pathways. Emphasis is placed on its cell-type-specific expression across neurons, astrocytes, microglia, and oligodendrocytes, and how this expression dynamically shifts under pathological contexts such as Parkinson’s disease, stroke, and demyelinating disorders. GPR37 modulates neuroinflammatory responses, apoptosis, and oxidative stress through context-dependent mechanisms shaped by its ligands, including prosaposin, neuroprotectin D1, and osteocalcin. Additionally, GPR37 dysfunction–especially via receptor misfolding and ER stress–contributes to neuronal vulnerability. We further discuss its emerging role as a pharmacological target and potential biomarker in CNS disorders. By integrating findings across molecular, cellular, and disease models, we propose a context-dependent framework positioning GPR37 as a multifunctional regulator and therapeutic candidate in neurodegeneration.
- 31 July 2025
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 19, 1617682
Open AccessRole and regulatory mechanism of GPR37 in neurological diseases
G protein-coupled receptor 37 is an orphan Class A GPCR predominantly expressed in the central nervous system (CNS), implicated in diverse physiological and pathological processes. This review summarizes current advances in the structural and functional understanding of GPR37, including its genomic localization, receptor architecture, endogenous ligands, and downstream signaling pathways. Emphasis is placed on its cell-type-specific expression across neurons, astrocytes, microglia, and oligodendrocytes, and how this expression dynamically shifts under pathological contexts such as Parkinson’s disease, stroke, and demyelinating disorders. GPR37 modulates neuroinflammatory responses, apoptosis, and oxidative stress through context-dependent mechanisms shaped by its ligands, including prosaposin, neuroprotectin D1, and osteocalcin. Additionally, GPR37 dysfunction–especially via receptor misfolding and ER stress–contributes to neuronal vulnerability. We further discuss its emerging role as a pharmacological target and potential biomarker in CNS disorders. By integrating findings across molecular, cellular, and disease models, we propose a context-dependent framework positioning GPR37 as a multifunctional regulator and therapeutic candidate in neurodegeneration.
- Open Access
- 7 July 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 923-929
Medical and endovascular treatment for acute large vessel occlusion with mild stroke: a real-world nationwide registry
Background Endovascular therapy (EVT) is standard treatment for large vessel occlusion in patients with a National Institutes of Health Stroke Scale (NIHSS) score ≥6, but its role in mild stroke (NIHSS score Objective To explore the association between EVT and clinical outcomes in mild stroke. Methods This study prospectively enrolled consecutive patients with a mild stroke at 35 comprehensive stroke centers in China between January 2020 and December 2023. Patients were categorized into primary EVT (pEVT) or best medical management (BMM) groups. The primary outcome was an excellent outcome (modified Rankin Scale (mRS) score ≤1). Secondary outcomes included a good outcome (mRS score ≤2) and lowering of the mRS score. Safety endpoints were mortality and symptomatic intracranial hemorrhage. Outcomes were compared between groups using multivariable logistic regression and inverse probability of treatment weighting (IPTW). Results Finally, 307 patients were included: 117 received pEVT, and 190 received BMM. In the IPTW model, pEVT was associated with higher excellent (aOR=3.6, 95% CI 2.5 to 5.2) and good (aOR=4.0, 95% CI 2.5 to 6.6) outcomes, lower mortality (aOR=0.1, 95% CI 0.01 to 0.4), and a lower 90-day mRS (aOR=0.2, 95% CI 0.1 to 0.3), with similar sICH rates. Among the BMM group, 80 patients (42.1%) experienced early neurological deterioration (END), with 55 receiving rescue EVT (rEVT), and were still included in BMM group. In the multivariable model, the rEVT was related with higher excellent (aOR=7.2, 95% CI 1.4 to 37.9) and good (aOR=4.1, 95% CI 1.2 to 14.8) outcomes and a lower mRS (aOR=2.0, 95% CI 0.9 to 4.8). Conclusions Primary EVT significantly increases the likelihood of achieving an excellent outcome in mild stroke. Over 40% of patients with a mild stroke treated with BMM experienced END, and rEVT effectively improved the prognosis.
- 7 July 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 923-929
Open AccessMedical and endovascular treatment for acute large vessel occlusion with mild stroke: a real-world nationwide registry
Background Endovascular therapy (EVT) is standard treatment for large vessel occlusion in patients with a National Institutes of Health Stroke Scale (NIHSS) score ≥6, but its role in mild stroke (NIHSS score Objective To explore the association between EVT and clinical outcomes in mild stroke. Methods This study prospectively enrolled consecutive patients with a mild stroke at 35 comprehensive stroke centers in China between January 2020 and December 2023. Patients were categorized into primary EVT (pEVT) or best medical management (BMM) groups. The primary outcome was an excellent outcome (modified Rankin Scale (mRS) score ≤1). Secondary outcomes included a good outcome (mRS score ≤2) and lowering of the mRS score. Safety endpoints were mortality and symptomatic intracranial hemorrhage. Outcomes were compared between groups using multivariable logistic regression and inverse probability of treatment weighting (IPTW). Results Finally, 307 patients were included: 117 received pEVT, and 190 received BMM. In the IPTW model, pEVT was associated with higher excellent (aOR=3.6, 95% CI 2.5 to 5.2) and good (aOR=4.0, 95% CI 2.5 to 6.6) outcomes, lower mortality (aOR=0.1, 95% CI 0.01 to 0.4), and a lower 90-day mRS (aOR=0.2, 95% CI 0.1 to 0.3), with similar sICH rates. Among the BMM group, 80 patients (42.1%) experienced early neurological deterioration (END), with 55 receiving rescue EVT (rEVT), and were still included in BMM group. In the multivariable model, the rEVT was related with higher excellent (aOR=7.2, 95% CI 1.4 to 37.9) and good (aOR=4.1, 95% CI 1.2 to 14.8) outcomes and a lower mRS (aOR=2.0, 95% CI 0.9 to 4.8). Conclusions Primary EVT significantly increases the likelihood of achieving an excellent outcome in mild stroke. Over 40% of patients with a mild stroke treated with BMM experienced END, and rEVT effectively improved the prognosis.
- Open Access
- 17 June 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (12) , e038173
Selection by Noncontrast Computed Tomography With or Without Computed Tomography Angiography Versus Computed Tomography Perfusion for Endovascular Therapy in Patients With Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
Background: The effect of imaging selection on endovascular therapy for acute ischemic stroke remains debated. We compared the efficacy and safety of imaging modalities using computed tomography perfusion with using noncontrast computed tomography (NCCT)±computed tomography angiography. Methods: Studies from PubMed, Embase, and Cochrane Library up to March 1, 2024, were analyzed. Sixteen studies (12 199 patients) assessed functional independence (modified Rankin Scale score of 0–2 at 90 days) using odds ratios (ORs). This study was registered with the International Prospective Register of Systematic Reviews (CRD42024519554). Results: No significant differences were observed in functional independence (OR, 1.09 [95% CI, 0.98–1.21]), modified Rankin Scale score of 0 to 1 (OR, 1.07 [95% CI, 0.88–1.29]), 0 to 3 (OR, 1.04 [95% CI, 0.92–1.18]), thrombolysis in cerebral infarction 2b to 3 (OR, 1.08 [95% CI, 0.95–1.22]), symptomatic intracranial hemorrhage (OR, 0.87 [95% CI, 0.74–1.04]), and any intracranial hemorrhage (OR, 0.95 [95% CI, 0.80–1.12]) between the computed tomography perfusion and NCCT group. There was a significantly lower odds of death during follow‐up in the computed tomography perfusion group compared with the NCCT group (OR, 0.78 [95% CI, 0.70–0.88]). Comparison of modified Rankin Scale score of 0 to 2 significantly favored NCCT selection for patients with large cores ( P interaction =0.05). Risk of bias assessment using the Cochrane risk assessment tool revealed concerns in 1 randomized control trial, while observational and post hoc studies assessed with Risk of Bias in Nonrandomized Studies of Interventions I showed moderate (2 studies), serious (11 studies), and critical (2 studies) risk of bias. Conclusions: These findings indicate that patients undergoing endovascular therapy selected with computed tomography perfusion had a similar functional prognosis compared with those selected with NCCT but had lower odds of death during follow‐up. NCCT‐defined large‐core patients had better functional outcomes.
- 17 June 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (12) , e038173
Open AccessSelection by Noncontrast Computed Tomography With or Without Computed Tomography Angiography Versus Computed Tomography Perfusion for Endovascular Therapy in Patients With Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
Background: The effect of imaging selection on endovascular therapy for acute ischemic stroke remains debated. We compared the efficacy and safety of imaging modalities using computed tomography perfusion with using noncontrast computed tomography (NCCT)±computed tomography angiography. Methods: Studies from PubMed, Embase, and Cochrane Library up to March 1, 2024, were analyzed. Sixteen studies (12 199 patients) assessed functional independence (modified Rankin Scale score of 0–2 at 90 days) using odds ratios (ORs). This study was registered with the International Prospective Register of Systematic Reviews (CRD42024519554). Results: No significant differences were observed in functional independence (OR, 1.09 [95% CI, 0.98–1.21]), modified Rankin Scale score of 0 to 1 (OR, 1.07 [95% CI, 0.88–1.29]), 0 to 3 (OR, 1.04 [95% CI, 0.92–1.18]), thrombolysis in cerebral infarction 2b to 3 (OR, 1.08 [95% CI, 0.95–1.22]), symptomatic intracranial hemorrhage (OR, 0.87 [95% CI, 0.74–1.04]), and any intracranial hemorrhage (OR, 0.95 [95% CI, 0.80–1.12]) between the computed tomography perfusion and NCCT group. There was a significantly lower odds of death during follow‐up in the computed tomography perfusion group compared with the NCCT group (OR, 0.78 [95% CI, 0.70–0.88]). Comparison of modified Rankin Scale score of 0 to 2 significantly favored NCCT selection for patients with large cores ( P interaction =0.05). Risk of bias assessment using the Cochrane risk assessment tool revealed concerns in 1 randomized control trial, while observational and post hoc studies assessed with Risk of Bias in Nonrandomized Studies of Interventions I showed moderate (2 studies), serious (11 studies), and critical (2 studies) risk of bias. Conclusions: These findings indicate that patients undergoing endovascular therapy selected with computed tomography perfusion had a similar functional prognosis compared with those selected with NCCT but had lower odds of death during follow‐up. NCCT‐defined large‐core patients had better functional outcomes.
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (6) , 1388-1395
Effects of Intensive Blood Pressure Lowering on Brain Swelling in Thrombolyzed Acute Ischemic Stroke: The ENCHANTED Results
BACKGROUND: Cerebral swelling in relation to cytotoxic edema is a predictor of poor outcome in acute ischemic stroke (AIS) and elevated blood pressure (BP) promotes its development. Whether intensive BP-lowering treatment reduces cerebral swelling is uncertain. We aimed to determine whether intensive BP lowering reduces the severity of cerebral swelling after thrombolysis for AIS. METHODS: A secondary analysis of the ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study), a partial factorial, international, multicenter, open-label, blinded end point, randomized controlled trial of alteplase dose and levels of BP control in thrombolyzed patients with AIS. Participants were randomly assigned to intensive (systolic target 130–140 mm Hg within 1 hour; maintained for 72 hours) or guideline-recommended (systolic target P =0.71). Results were consistent across different groups of swelling severity (swelling score 2–6, 3–6, and 4–6; and ordinal shift on swelling score). CONCLUSIONS: Modest early intensive BP lowering does not seem to alter cerebral swelling in thrombolyzed patients with AIS. Further research is needed to quantify brain edema to allow a better understanding of the complex relations of BP and outcomes from AIS. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01422616.
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (6) , 1388-1395
Effects of Intensive Blood Pressure Lowering on Brain Swelling in Thrombolyzed Acute Ischemic Stroke: The ENCHANTED Results
BACKGROUND: Cerebral swelling in relation to cytotoxic edema is a predictor of poor outcome in acute ischemic stroke (AIS) and elevated blood pressure (BP) promotes its development. Whether intensive BP-lowering treatment reduces cerebral swelling is uncertain. We aimed to determine whether intensive BP lowering reduces the severity of cerebral swelling after thrombolysis for AIS. METHODS: A secondary analysis of the ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study), a partial factorial, international, multicenter, open-label, blinded end point, randomized controlled trial of alteplase dose and levels of BP control in thrombolyzed patients with AIS. Participants were randomly assigned to intensive (systolic target 130–140 mm Hg within 1 hour; maintained for 72 hours) or guideline-recommended (systolic target P =0.71). Results were consistent across different groups of swelling severity (swelling score 2–6, 3–6, and 4–6; and ordinal shift on swelling score). CONCLUSIONS: Modest early intensive BP lowering does not seem to alter cerebral swelling in thrombolyzed patients with AIS. Further research is needed to quantify brain edema to allow a better understanding of the complex relations of BP and outcomes from AIS. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01422616.
- Open Access
- 15 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Validation of a novel CT perfusion software compared to RAPID in stroke patients receiving endovascular therapy
Accurate estimate of ischemic core volume (ICV) and penumbra volume (PV) is important in decision-making for endovascular therapies (EVT) and predicting the patient’s clinical outcome. In this study, we compared the performance of a novel automated CT perfusion software UGuard and the Rapid Processing of Perfusion and Diffusion (RAPID). UGuard and RAPID had strong agreement with regard to ICV (ICC 0.92, 95% CI 0.89 – 0.94) and PV (ICC 0.8, 95% CI 0.73 – 0.85) measurements. ICVs measured by UGuard or RAPID were similar in predicting favorable outcome (AUC 0.72 vs. 0.70, P = 0.43), with UGuard measurements having higher specificity. After adjusting for significant clinical covariates, the predictive performance of favorable outcome was excellent for each of the six models incorporating ICV and PV, and the model which incorporated ICV and PV measured by UGuard software package showed the best predictive performance. We concluded that the ICV and PV of CT perfusion images measured by UGuard software package, as well as the capacity to predict favorable outcome of patients following EVT, were comparable to RAPID.
- 15 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Open AccessValidation of a novel CT perfusion software compared to RAPID in stroke patients receiving endovascular therapy
Accurate estimate of ischemic core volume (ICV) and penumbra volume (PV) is important in decision-making for endovascular therapies (EVT) and predicting the patient’s clinical outcome. In this study, we compared the performance of a novel automated CT perfusion software UGuard and the Rapid Processing of Perfusion and Diffusion (RAPID). UGuard and RAPID had strong agreement with regard to ICV (ICC 0.92, 95% CI 0.89 – 0.94) and PV (ICC 0.8, 95% CI 0.73 – 0.85) measurements. ICVs measured by UGuard or RAPID were similar in predicting favorable outcome (AUC 0.72 vs. 0.70, P = 0.43), with UGuard measurements having higher specificity. After adjusting for significant clinical covariates, the predictive performance of favorable outcome was excellent for each of the six models incorporating ICV and PV, and the model which incorporated ICV and PV measured by UGuard software package showed the best predictive performance. We concluded that the ICV and PV of CT perfusion images measured by UGuard software package, as well as the capacity to predict favorable outcome of patients following EVT, were comparable to RAPID.
- Open Access
- 3 March 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1473802
J-shaped association of neutrophil-to-lymphocyte ratio with all-cause mortality and linear association with cardiovascular mortality in stroke survivors
Background: The correlation between systemic inflammation and stroke has been well-established. Notably, the neutrophil-to-lymphocyte ratio (NLR) has been linked to poor outcomes and increased short-term mortality in acute ischemic stroke (AIS). This study aims to explore the association between NLR and long-term mortality among stroke survivors.Methods: This study analyzed data from 1,229 stroke survivors enrolled in the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2018. The participants were categorized according to quartiles of NLR level. Multivariate Cox regression and restricted cubic splines (RCS) were applied to evaluate the relationship between NLR and all-cause and cardiovascular disease (CVD) mortality.Results: Over a median follow-up of 6.41 years, 485 deaths were recorded. After multivariate adjustment, individuals in the highest NLR quartile (Q4) demonstrated significantly higher risks of all-cause mortality (hazard ratio [HR] = 1.58, 95% confidence interval [CI]: 1.06–2.34) and CVD mortality (HR = 1.90, 95% CI: 1.07–3.37) compared to those in the lowest quartile (Q1). RCS analysis revealed a J-shaped relationship between NLR and all-cause mortality and a linear relationship with CVD mortality.Conclusion: These findings suggest a J-shaped association between NLR and all-cause mortality, along with a linear relationship between NLR and CVD mortality in stroke survivors.
- 3 March 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1473802
Open AccessJ-shaped association of neutrophil-to-lymphocyte ratio with all-cause mortality and linear association with cardiovascular mortality in stroke survivors
Background: The correlation between systemic inflammation and stroke has been well-established. Notably, the neutrophil-to-lymphocyte ratio (NLR) has been linked to poor outcomes and increased short-term mortality in acute ischemic stroke (AIS). This study aims to explore the association between NLR and long-term mortality among stroke survivors.Methods: This study analyzed data from 1,229 stroke survivors enrolled in the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2018. The participants were categorized according to quartiles of NLR level. Multivariate Cox regression and restricted cubic splines (RCS) were applied to evaluate the relationship between NLR and all-cause and cardiovascular disease (CVD) mortality.Results: Over a median follow-up of 6.41 years, 485 deaths were recorded. After multivariate adjustment, individuals in the highest NLR quartile (Q4) demonstrated significantly higher risks of all-cause mortality (hazard ratio [HR] = 1.58, 95% confidence interval [CI]: 1.06–2.34) and CVD mortality (HR = 1.90, 95% CI: 1.07–3.37) compared to those in the lowest quartile (Q1). RCS analysis revealed a J-shaped relationship between NLR and all-cause mortality and a linear relationship with CVD mortality.Conclusion: These findings suggest a J-shaped association between NLR and all-cause mortality, along with a linear relationship between NLR and CVD mortality in stroke survivors.
- Open Access
Medical and Endovascular Treatment for Acute Large Vessel Occlusion with Mild Stroke: A Real-World Nationwide Registry
Background and Purpose EVT is a standard treatment for LVO in patients with an NIHSS score ≥6, but its role in mild stroke (NIHSS Methods This non-randomized cohort study prospectively enrolled consecutive mild stroke patients at 35 comprehensive stroke centers across 15 Chinese provinces from January 2020 to December 2023. Patients were categorized into pEVT or BMM groups, including those who received rEVT after deterioration. The primary outcome was an excellent outcome (mRS score of 0-1) at 90 days. Secondary outcomes included a good outcome (mRS score of 0-2) and mRS shift. Safety endpoints were mortality and sICH. Outcomes were compared between groups using multivariable logistic regression and IPTW. Results Finally, 307 patients were included. 110 received pEVT, and 190 received BMM. In the IPTW model, the pEVT group had higher rates of excellent (aOR=3.6, 95%CI=2.5-5.2) and good (aOR=4.0, 95%CI=2.5-5.6) outcomes, lower mortality (aOR=0.1, 95%CI=0.01-0.4), and a better 90-day mRS shift (aOR=0.2, 95%CI=0.1-0.3,), with similar sICH rates. Among the BMM group, 80 patients (42.1%) experienced early neurological deterioration (END), with 55 receiving rEVT. In the multivariable model, the pEVT group had higher rates of excellent (aOR=7.2, 95%CI=1.4-37.9) and good (aOR=4.1, 95%CI=1.2-14.8) outcomes and a better mRS shift (aOR=2.0, 95%CI=0.9-4.8). Conclusions Primary EVT significantly increases the likelihood of achieving an excellent outcome in mild stroke. Over 40% of mild stroke patients treated with BMM experienced END, and rEVT effectively improved the prognosis. Question What is the optimal strategy for mild stroke with LVO? Findings This national prospective registry study demonstrated that pEVT significantly improved the prognosis of mild stroke patients with LVO compared to BMM. Approximately 40% of patients in the BMM group experienced END, and rEVT increased the likelihood of an excellent outcome in these patients. Meaning Primary EVT can significantly increase the probability of an excellent outcome in patients with mild stroke and LVO. Over 40% of patients with mild stroke treated with BMM experienced END, and rEVT effectively improved their prognosis.
Open AccessMedical and Endovascular Treatment for Acute Large Vessel Occlusion with Mild Stroke: A Real-World Nationwide Registry
Background and Purpose EVT is a standard treatment for LVO in patients with an NIHSS score ≥6, but its role in mild stroke (NIHSS Methods This non-randomized cohort study prospectively enrolled consecutive mild stroke patients at 35 comprehensive stroke centers across 15 Chinese provinces from January 2020 to December 2023. Patients were categorized into pEVT or BMM groups, including those who received rEVT after deterioration. The primary outcome was an excellent outcome (mRS score of 0-1) at 90 days. Secondary outcomes included a good outcome (mRS score of 0-2) and mRS shift. Safety endpoints were mortality and sICH. Outcomes were compared between groups using multivariable logistic regression and IPTW. Results Finally, 307 patients were included. 110 received pEVT, and 190 received BMM. In the IPTW model, the pEVT group had higher rates of excellent (aOR=3.6, 95%CI=2.5-5.2) and good (aOR=4.0, 95%CI=2.5-5.6) outcomes, lower mortality (aOR=0.1, 95%CI=0.01-0.4), and a better 90-day mRS shift (aOR=0.2, 95%CI=0.1-0.3,), with similar sICH rates. Among the BMM group, 80 patients (42.1%) experienced early neurological deterioration (END), with 55 receiving rEVT. In the multivariable model, the pEVT group had higher rates of excellent (aOR=7.2, 95%CI=1.4-37.9) and good (aOR=4.1, 95%CI=1.2-14.8) outcomes and a better mRS shift (aOR=2.0, 95%CI=0.9-4.8). Conclusions Primary EVT significantly increases the likelihood of achieving an excellent outcome in mild stroke. Over 40% of mild stroke patients treated with BMM experienced END, and rEVT effectively improved the prognosis. Question What is the optimal strategy for mild stroke with LVO? Findings This national prospective registry study demonstrated that pEVT significantly improved the prognosis of mild stroke patients with LVO compared to BMM. Approximately 40% of patients in the BMM group experienced END, and rEVT increased the likelihood of an excellent outcome in these patients. Meaning Primary EVT can significantly increase the probability of an excellent outcome in patients with mild stroke and LVO. Over 40% of patients with mild stroke treated with BMM experienced END, and rEVT effectively improved their prognosis.